These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36677015)

  • 1. Simultaneous Quantification of Serum Lipids and Their Association with Type 2 Diabetes Mellitus-Positive Hepatocellular Cancer.
    Yue Z; Pei L; Meng G; Zhang A; Li M; Jia M; Wang H; Cao L
    Metabolites; 2023 Jan; 13(1):. PubMed ID: 36677015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical potential of serum prostaglandin A2 as a novel diagnostic biomarker for hepatocellular cancer.
    Liu L; Li YN; Zhang A; Yin Y; Yue Z; Pei L; Xia CS; Wang D; Jia M; Wang H; Cao LL
    Clin Chim Acta; 2024 Jul; 561():119814. PubMed ID: 38879063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Serum Metabolite Classifier for the Early Detection of Type 2 Diabetes Mellitus-Positive Hepatocellular Cancer.
    Cao LL; Han Y; Pei L; Yue ZH; Liu BY; Cui JW; Jia M; Wang H
    Metabolites; 2022 Jul; 12(7):. PubMed ID: 35888734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA signature in patients with hepatocellular carcinoma associated with type 2 diabetes.
    Elemeery MN; Mohamed MA; Madkour MA; Shamseya MM; Issa NM; Badr AN; Ghareeb DA; Pan CH
    World J Gastroenterol; 2019 Nov; 25(42):6322-6341. PubMed ID: 31754293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic Profiling Identified a Novel Biomarker Panel for Metabolic Syndrome-Positive Hepatocellular Cancer.
    Cao LL; Han Y; Wang Y; Pei L; Yue Z; Qin L; Liu B; Cui J; Jia M; Wang H
    Front Endocrinol (Lausanne); 2021; 12():816748. PubMed ID: 35154012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Potential of Serum Exosomal hsa_circ_0028861 as the Novel Diagnostic Biomarker of HBV-Derived Hepatocellular Cancer.
    Wang Y; Pei L; Yue Z; Jia M; Wang H; Cao LL
    Front Genet; 2021; 12():703205. PubMed ID: 34367259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycopeptide Biomarkers in Serum Haptoglobin for Hepatocellular Carcinoma Detection in Patients with Nonalcoholic Steatohepatitis.
    Zhu J; Huang J; Zhang J; Chen Z; Lin Y; Grigorean G; Li L; Liu S; Singal AG; Parikh ND; Lubman DM
    J Proteome Res; 2020 Aug; 19(8):3452-3466. PubMed ID: 32412768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced detection of early hepatocellular carcinoma by serum SELDI-TOF proteomic signature combined with alpha-fetoprotein marker.
    Chen L; Ho DW; Lee NP; Sun S; Lam B; Wong KF; Yi X; Lau GK; Ng EW; Poon TC; Lai PB; Cai Z; Peng J; Leng X; Poon RT; Luk JM
    Ann Surg Oncol; 2010 Sep; 17(9):2518-25. PubMed ID: 20354800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma lipidic fingerprint associated with type 2 diabetes in patients with coronary heart disease: CORDIOPREV study.
    Villasanta-Gonzalez A; Mora-Ortiz M; Alcala-Diaz JF; Rivas-Garcia L; Torres-Peña JD; Lopez-Bascon A; Calderon-Santiago M; Arenas-Larriva AP; Priego-Capote F; Malagon MM; Eichelmann F; Perez-Martinez P; Delgado-Lista J; Schulze MB; Camargo A; Lopez-Miranda J
    Cardiovasc Diabetol; 2023 Aug; 22(1):199. PubMed ID: 37537576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ITIH4: Effective Serum Marker, Early Warning and Diagnosis, Hepatocellular Carcinoma.
    Li X; Li B; Li B; Guo T; Sun Z; Li X; Chen L; Chen W; Chen P; Mao Y; Zeng Y
    Pathol Oncol Res; 2018 Jul; 24(3):663-670. PubMed ID: 28828637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Large-Scale Multicenter Study Validates Aldo-Keto Reductase Family 1 Member B10 as a Prevalent Serum Marker for Detection of Hepatocellular Carcinoma.
    Ye X; Li C; Zu X; Lin M; Liu Q; Liu J; Xu G; Chen Z; Xu Y; Liu L; Luo D; Cao Z; Shi G; Feng Z; Deng H; Liao Q; Cai C; Liao DF; Wang J; Jin J; Cao D
    Hepatology; 2019 Jun; 69(6):2489-2501. PubMed ID: 30672601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring fucosylated alpha-fetoprotein in hepatocellular carcinoma: A comparison of μTAS and parallel reaction monitoring.
    Kim KH; Lee SY; Baek JH; Lee SY; Kim JY; Yoo JS
    Proteomics Clin Appl; 2021 Jul; 15(4):e2000096. PubMed ID: 33764665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver Cancer-Specific Serine Protease Inhibitor Kazal Is a Potentially Novel Biomarker for the Early Detection of Hepatocellular Carcinoma.
    Lu F; Shah PA; Rao A; Gifford-Hollingsworth C; Chen A; Trey G; Soryal M; Talat A; Aslam A; Nasir B; Choudhry S; Ishtiaq R; Sanoff H; Conteh LF; Noonan A; Hu KQ; Schmidt C; Fu M; Civan J; Xiao G; Lau DT; Lu X
    Clin Transl Gastroenterol; 2020 Dec; 11(12):e00271. PubMed ID: 33512798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipidomic analysis of serum exosomes identifies a novel diagnostic marker for type 2 diabetes mellitus.
    Zhang L; Lu T; Zhou B; Sun Y; Wang L; Qiao G; Yang T
    Lab Med; 2024 May; ():. PubMed ID: 38809765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower alpha fetoprotein and higher risk of hepatocellular carcinoma, study from the type 2 diabetes mellitus patients.
    Yang S; Liu L; Luo Y; Chen M; Li N; Xu L; Wang Y; Lin Z; Li H; Qu S
    Diabetes Res Clin Pract; 2018 Sep; 143():239-244. PubMed ID: 30009939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LC/MS-Based Global Metabolomic Identification of Serum Biomarkers Differentiating Hepatocellular Carcinoma from Chronic Hepatitis B and Liver Cirrhosis.
    Pan HY; Wu QQ; Yin QQ; Dai YN; Huang YC; Zheng W; Hui TC; Chen MJ; Wang MS; Zhang JJ; Huang HJ; Tong YX
    ACS Omega; 2021 Jan; 6(2):1160-1170. PubMed ID: 33490775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Fibroblast Growth Factor 19 and Total Bile Acid Concentrations Are Potential Biomarkers of Hepatocellular Carcinoma in Patients with Type 2 Diabetes Mellitus.
    Sun Y; Zhu M; Zhao H; Ni X; Chang R; Su J; Huang H; Cui S; Wang X; Yuan J; Yuan J; OuYang R; Zhang R; Chen W; Gu Y; Sun Y
    Biomed Res Int; 2020; 2020():1751989. PubMed ID: 32104677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative proteomic signature of liver cancer cells: tissue transglutaminase 2 could be a novel protein candidate of human hepatocellular carcinoma.
    Sun Y; Mi W; Cai J; Ying W; Liu F; Lu H; Qiao Y; Jia W; Bi X; Lu N; Liu S; Qian X; Zhao X
    J Proteome Res; 2008 Sep; 7(9):3847-59. PubMed ID: 18646787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum miR-224 as a biomarker for detection of hepatocellular carcinoma at early stage.
    Lin L; Lu B; Yu J; Liu W; Zhou A
    Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):397-404. PubMed ID: 26724963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum lipidomic profiling as a useful tool for screening potential biomarkers of hepatitis B-related hepatocellular carcinoma by ultraperformance liquid chromatography-mass spectrometry.
    Passos-Castilho AM; Carvalho VM; Cardozo KH; Kikuchi L; Chagas AL; Gomes-Gouvêa MS; Malta F; de Seixas-Santos Nastri AC; Pinho JR; Carrilho FJ; Granato CF
    BMC Cancer; 2015 Dec; 15():985. PubMed ID: 26680993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.